Iclos Uruguay (originally known as Clausen) was founded in the early 20th century with a strong focus on the manufacture of chemicals. In 2007, the company’s current production plant was opened, becoming the first biological product plant in the country and the only one approved by the European Medicines Agency (EMA) in Uruguay. Now-a-days, Iclos Uruguay has a high-tech pharmaceutical plant in over 6,500 square meters, comprising two production plants following the most demanding international standards.

Gemabiotech is a member of AMEGA Biotech, the biopharmaceutical platform integrating development and production operations, designing all processes, from clone selection to purified protein production, and finished products formulation.
AMEGA has a team specialized in the development of biosimilars. The company has all necessary facilities, from molecular biology, cell culture and downstream process development, to a pre-clinical studies department, where more than 15 bacterial and mammalian processes are developed.